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 11 
Temperate bacteriophages play an underestimated role in microbial infection and disease progression as they 12 
carry genes that promote positive evolutionary selection for the lysogen. Using Biolog phenotype microarrays and 13 
comparative metabolite profiling we demonstrate the impact of the well-characterised Shiga toxin-prophage 14 
ɸ24B on its Escherichia coli host MC1061. As a lysogen, the prophage alters the bacterial physiology by increasing 15 
the rates of respiration and cell proliferation. This is the first reported study detailing phage-mediated control of 16 
the E. coli biotin and fatty acid synthesis that is rate limiting to cell growth and antimicrobial tolerance to 17 
chloroxylenol and 8-hydroxyquinoline. Distinct metabolite profiles discriminate between MC1061 and the ɸ24B 18 
lysogen in standard culture, and when treated with the 2 antimicrobials. This is also the first reported use of 19 
metabolite profiling to characterise the physiological impact of lysogeny under antimicrobial pressure. We 20 
propose that temperate phages do not need to carry antimicrobial resistance genes to play a significant role in 21 
tolerance to antimicrobials. 22 
  23 
Introduction 24 
Colonisation by Shiga toxin-encoding Escherichia coli (STEC) causes a potentially fatal gastrointestinal infection in 25 
humans. There are currently > 500 different characterised STEC serogroups that cause disease including O157:H7 26 
and more recently O104:H4 (1, 2). Symptoms of STEC infection can vary from bloody diarrhoea through to 27 
haemorrhagic colitis, thrombotic thrombocytopaenic purpura (TTP) and haemolytic-uraemic syndrome (HUS) the 28 
latter can be fatal (3, 4). STEC is a zoonotic infection transmitted from an animal reservoir via contaminated food 29 
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or water (5). Shiga toxins are responsible for the severe downstream sequelae due to high cytotoxicity to human 30 
renal microvascular endothelial cells (4, 6). Importantly, the genes encoding Shiga toxin (Stx) are disseminated by 31 
temperate bacteriophages.   32 
Stx-phages enter one of two replication pathways, a productive lytic life cycle or a more passive 33 
lysogenic cycle where the prophage is replicated by the bacterium as any other genetic loci. The lytic-34 
lysogen decision of lambdoid-like bacteriophages is regulated by early gene expression and sequential 35 
binding of proteins to a well characterised genetic switch (7-9). 36 
The co-evolutionary interaction between a phage and its bacterial host is dynamic, with interplay linked 37 
to rounds of inhibition, selection and evolution, often referred to as an ‘arms race’ (10). Smith et al., 38 
(2007) used a multi-loci PCR typing approach to demonstrate that no 2 Stx phage isolates had the same 39 
genotype (11). This heterogeneity is further supported by Bonanno et al. (2016) who identified multiple 40 
Stx-phage morphologies not previously reported (12). Stx-phages are closely related to bacteriophage 41 
lambda, with a comparable genome organisation. In comparison to lambda, Stx-phages carry 42 
significantly larger amounts of DNA (~20-25 Kbp) with up to 73 % of the genome and putative coding 43 
genes having no known function when analysed at either the nucleotide or protein level (13). 44 
Nevertheless these genes are well conserved across many Stx-phages and thus likely to be important to 45 
the biology of the phage or its bacterial host (13). Upon phage infection and conversion to a lysogen, 46 
genes that are accessory to the core biology of the phage may offer a selective advantage to the host. Mis-47 
excision, mis-packaging of phage DNA (14) and recombination (15) play a large role in phage genome variation. 48 
This may leave phage DNA regions, remnant or cryptic prophages that positively impact on the selection and 49 
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survival of both the phage and the bacterium (16). This is further supported by the common occurrence of 50 
prophage regions, usually multiple, in the chromosomes of many bacterial pathogens (17).  51 
There are a number of features of the Shigatoxigenic phage vB_EcoPφ24B  or φ24B that are particularly 52 
relevant to the success and persistence of Stx prophages in E. coli. In contrast to the lambda infection 53 
model, φ24B can multiply infect a bacterial host (18-20). Stx-phages have been isolated from a wide 54 
variety of environments where E.coli is present and this has undoubtedly been promoted by the use of 55 
an essential outer membrane protein BamA as the adsorption site (21); this interaction is conserved in 56 
Stx-phages as the incidence of the tail and host recognition protein is widespread (21). ɸ24B has also 57 
been shown to survive well in compost models (22), also showing infectivity after 30 days in bovine 58 
manure and slurry (23). φ24B is genetically similar to phages isolated from sporadic outbreaks of STEC 59 
with high virulence and therefore a good model of the viruses circulating in E. coli populations in the 60 
environment (13). 61 
The ability of lambdoid like phages to increase virulence by carriage of toxins in their accessory genome (24) is 62 
well described e.g. the cholera toxin (CTX) carried by Vibrio cholera phage (25, 26). In Stx-phage genomes the 63 
shigatoxin genes are always located at the same position on the phage genome, upstream of the Q antiterminator 64 
gene therefore organisation and gene location is important (27). It has been hypothesised that presence of stx 65 
also offers selection and stability for the lysogens (28). Colon et al., (2016) observed that Stx-prophages show 66 
greater levels of spontaneous induction than lambda but this more readily correlates to Rec dependant and 67 
independent control of the CI repressor protein rather than presence or absence of stx (29).  68 
Other accessory genes that are seemingly superfluous to viral replication have been shown to aid microbial 69 
selection against environmental stress. Examples include: antibiotic resistance (30, 31), acid tolerance (32, 33) 70 
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and polylysogeny (34). Phage gene expression has also been shown to aid adhesion and colonisation, for example 71 
the expression of the λ-encoded lom gene promotes adhesion to buccal epithelial cells (35), and the λ-encoded 72 
bor confers serum resistance (36). Other phage encoded virulence traits include exotoxin production in E. coli (37) 73 
and increase in bacterial invasion via Staphylococcus phage encoded kinase that influences fibrinolysis (38). 74 
Bacteriophage φ24B has also been shown to encode a mi-RNA in the lom region that alters expression of anti-75 
repressor d-ant and downstream activity of CI, leading to rapid induction (39). Tree et al., (2014) identified 55 76 
prophage regions encoding small regulatory RNA within the Sakai E. coli O157:H7 strain (40). These small 77 
prophage anti-sRNA had the ability to form complexes or mimic core genome regulatory sRNA to aid selective 78 
advantage to the bacterial host in bovine rectal mucus. Stx-phage φ24B shows 98% sequence homology at the 79 
nucleotide level to the remnant Stx2 phage present in the Sakai genome (13). 80 
The function of the large numbers of hypothetical proteins encoded by φ24B and other converting phage is 81 
difficult to determine, and a focus of this study, as gene expression or interaction may be specific to an 82 
environment or subject to selective pressure. Therefore current approaches in vitro using synchronous cultures 83 
and standard laboratory conditions to investigate the role of these prophages are critically flawed. The function of 84 
these hypothetical gene products and how they impact the host in either an advantageous or deleterious way 85 
may be missed. In this study we focus on phage mediated antimicrobial tolerance to antibiotics found in the 86 
livestock farm setting which is the primary reservoir of pathogenic shigatoxigenic E. coli. 87 
Our principal aim was to identify how infection and integration of φ24B changes the microbial physiology, and 88 
how phage conversion aids selection compared to its naïve counterpart. This study demonstrates an increase in 89 
cell proliferation in standard culture, respiration activity using the Biolog phenotypic array and antimicrobial 90 
tolerance that is not linked to an identifiable resistance gene-cassette. The Biolog phenotypic array is a good 91 
tool for rapidly identifying phenotypic changes in the respiration profiles of bacteria (41, 42).  This study 92 
also presents an untargeted metabolomics approach to reveal key phage-mediated differences in metabolism 93 
directly linked to biotin and fatty acid synthesis. Interestingly, we show that integration of φ24B into its primary 94 
integration site located 250 bp upstream of the IntS gene (43) allows converted E. coli MC1061 to grow using 95 
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alternative sources of phosphate compared to the naïve bacterial host. We show for the first time unique changes 96 
in bacterial metabolite profiles on phage conversion in response to sub-inhibitory concentrations of antimicrobial 97 
agents.  98 
 99 
Results  100 
φ24B integration increases cell proliferation. Growth rates of bacteria can differ due to a range of environmental 101 
parameters. To investigate the impact of φ24B on E. coli, viable cell counts were determined during growth 102 
comparing E. coli B strain MC1061 to single and double lysogens, the latter integrated into separate locations in 103 
the MC1061 chromosome (43). Under standard growth conditions, the single and double lysogens showed 104 
significantly higher early growth rates compared to the naïve MC1061 (>200 %, Figure 1). This correlates to an 105 
increased doubling time of 17 mins for the single lysogen compared to 20 minutes for the naïve MC1061 and 16 106 
mins for the double lysogen. As the cultures reached mid to late exponential growth, the differences in growth 107 
rates diminished (Figure 1). Increase in growth rate was restricted to early growth (Figure 1). This was supported 108 
by a shorter lag time in the single and double lysogen compared to MC1061 with a 0.5 and 1.8 fold increase 109 
respectively in cell number after the first hour of growth.  Stationary phase in the double lysogen is achieved 110 
earlier compared to MC1061 and the single lysogen as nutrients are utilised rapidly alongside the accumulation of 111 
inhibitory components of growth. 112 
φ24B integration alters utilisation of different mono-phosphates and inability to respire using βD-Allose. To 113 
explore the single lysogen related differences in cell respiration during growth we used the Biolog Phenotype 114 
MicroArray. This determined functional changes in respiration and metabolism resulting from phage conversion 115 
over a 48 h period with recordings taken every 15 min. The lysogen acquired the ability to respire and grow 116 
utilising uridine-2-monophosphate (U-2-P) when compared to the naïve MC1061 (SI Figure 1, panel A). Phage 117 
mediated subversion of pyrimidine and purine synthesis by lytic phages has been previously reported and will be 118 
discussed later. Conversely, integration of the phage inhibited the lysogens ability to use D-Allose for respiration. 119 
φ24B integration alters resistance to osmotic stress or antimicrobials. Again using the Biolog phenotypic array 120 
the single lysogen is able to tolerate a range of antimicrobial agents that have both extracellular and intracellular 121 
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targets (Figure 2). The respiration curves derived for this experiment are provided in the supplementary 122 
information (SI - Figures 1 and 2). Tests showing differences in respiration profile were determined in the 123 
presence of 22 antimicrobials and 7 increases in salt concentration (SI Table 2).Of these 29 different tests, the 124 
lysogen showed a level of tolerance to 17 antimicrobials (SI Table 2). Data presented in Figure 2 (n=3) are 125 
comparisons of the area under the respiration curve illustrating those that were altered significantly. φ24B 126 
infection promotes tolerance to 8-hydroxyquinoline (P <0.000), chloroxylenol (P <0.0037), and cefmetazole (P 127 
<0.0026), cefoxitin, (P <0.015) cefomendole (P <0.0239) and  amoxacillin (P <0.057). Integration of ɸ24B into the 128 
primary site 250 bp upstream of IntS inhibits respiration utilising B-D-allose. Lysogeny also limits cell respiration in 129 
the presence of oxolinic acid although this is linked to phage induction as the cellular target is DNA gyrase. 130 
Inhibition of DNA gyrase has been previously shown to stimulate temperate phages to the lytic life cycle as 131 
cellular stress stimulates RecA, lexA and proteolytic cleavage of the repressor protein promoting phage induction 132 
(44). 133 
φ24B integration increases MC1061 tolerance to sub-inhibitory concentrations of chloroxylenol and 8-134 
hydroxyquinoline. To better understand the level of antimicrobial tolerance of the single lysogen, we first 135 
determined sub-inhibitory concentrations (SIC) against both MC1061 and the lysogen that reduce cell growth by ~ 136 
60 %. The antimicrobials chloroxylenol, oxolinic acid and 8-hydroxyquinoline were selected to validate the Biolog 137 
data. Prior to comparison, an approximate SIC range was determined for MC1061 utilising each of the 3 test 138 
drugs. Figure 3 illustrates increased tolerance in a dose dependent response by the lysogen in the presence of 139 
chloroxylenol and 8-hydroxyquinoline. Conversely, the naïve host shows increased tolerance compared to the 140 
lysogen in the presence of oxolinic acid. This also offers a positive control for the assay as oxolinic acid targets 141 
DNA gyrase and therefore stimulates phage induction (26). Phage induction was confirmed by the presence of 142 
free phage compared to the un- induced control (data not shown). 143 
 144 
Metabolic profiles comparing naïve MC1061 to ɸ24B Lysogen. We used an untargeted metabolite profiling 145 
approach using high resolution LC-MS (≤1 ppm mass accuracy in full scan) to determine metabolic differences 146 
between bacterial host and lysogen during growth and when challenged with a sub-inhibitory concentration of test 147 
antibiotic. To broadly compare findings, significant metabolic differences (p < 0.05) were observed between both 148 
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growth phase and antimicrobial challenge.  In total, >11K ion features or possible metabolites were determined 149 
across all of the different tests performed. Of these 81 showed discrimination between the naïve MC1061 and the 150 
ɸ24B lysogen that had clean chromatogram peaks and < 5% coefficient variable (CV) (SI table 3). These 81 151 
metabolites that show differences can be further stratified to each test.  152 
The metabolite data were analysed using supervised and non-supervised multivariate analysis. Principal 153 
Component Analysis was first employed to visualise trends in the dataset and identify potential outliers. To further 154 
interrogate the data, Partial-Least Squared Discriminant Analysis models (PLS-DA) were generated and score plots 155 
are shown in (Figure 4 A-C). The PLS-DA models for both hydroxyquinoline and chloroxylenol conditions score 156 
plots had good discriminating ability, establishing the metabolic differences between the lysogen and naïve host. 157 
During standard growth conditions component 1 failed to discriminate: Q2 -0.556, R2Y 0.262, as R2Y and Q2 158 
<0.5, although certain metabolites showed significant differences between the lysogen and MC1061. The 8-159 
hydroxyquinoline component 1: Q2 0.74, R2Y 0.89 and the chloroxylenol component 1: Q2 0.802, R2Y 0.923 160 
were both discriminatory with an R2Y and Q2 > 0.5. Further model statistics can be found in the supplementary 161 
information SI table 5. Stx-phage φ24B has been previously shown to undergo spontaneous induction (27) and may 162 
impact the metabolite profile through sequestration of host function and movement to lysis. We therefore compared 163 
the metabolite profiles of both the lysogen and MC1061 with a phage inducing agent, oxolinic acid (DNA gyrase 164 
inhibitor). No correlation was seen between metabolite profiles of the lysogen or MC1061 when compared to that 165 
of the lysogen undergoing induction with oxolinic acid (data not shown). 166 
 167 
ɸ24B integration alters the metabolite profile of MC1061 in standard growth conditions. Out of the 81 168 
discriminatory metabolites the standard culture condition had 16 metabolites shown to discriminate between the 169 
naïve host and single lysogen. Of these 16 metabolites 4 were found in higher levels in the lysogen. This suggests 170 
that the lysogen down regulates certain metabolic functions or is directing metabolism along a different pathway. It 171 
is likely to support the change in biology we report in this work and increased rates of early growth by the lysogen.  172 
Early growth in the lysogen demonstrates an observable difference in metabolic profile compared to the naïve 173 
MC1061. Under standard growth conditions during early growth, 5 metabolites in total were shown to discriminate 174 
between the naïve MC1061 and lysogen. Of these, 1 was higher compared to the naïve control (Figure 3 SI). 175 
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During stationary phase, in standard growth conditions, only 9 metabolites in total showed significant difference 176 
and all were found in lower levels in the lysogen.  177 
As phage-mediated metabolic differences are present during standard culture, the differences in metabolite profiles 178 
under challenge with sub-inhibitory concentrations of 8-hydroxyquinoline and chloroxylenol were tested (Figure 2 179 
B and C). The previous Biolog results showed that the lysogen displays a tolerance to these 2 antibiotics. 180 
ɸ24B integration alters the metabolite profile of MC1061 during growth under sub-inhibitory concentrations of 181 
8-hydroxyquinoline. Upon treatment with 8-hydroxyquinoline, there were 29 metabolites that showed significant 182 
difference between the naïve MC1061 and single lysogen. Of these 29 metabolites, 22 were found in higher levels 183 
in the lysogen. Early growth phase in the lysogen demonstrates an observable difference in metabolic change 184 
compared to the naïve MC1061. Under 8-hydroxyquinoline stress during early growth, 6 metabolites in total were 185 
shown to discriminate between the naïve MC1061 and lysogen. Of these, 5 were higher compared to the naïve 186 
control (Figure 3 SI).  187 
ɸ24B integration alters the metabolite profile of MC1061 during growth under sub-inhibitory concentrations of 188 
chloroxylenol. Under chloroxylenol treatment, 41 metabolites showed significant differences between the naïve 189 
MC1061 and lysogen. Of these 41, the lysogen had 22 metabolites with significantly higher levels compared to the 190 
naïve host. Early growth phase in the lysogen demonstrates an observable difference in metabolic change compared 191 
to the naïve MC1061. Under chloroxylenol stress during early growth, 13 metabolites in total were shown to 192 
discriminate between the naïve MC1061 and lysogen. Of these, 9 were higher compared to the naïve control 193 
(Figure 3 SI).  194 
Alteration in metabolomics profile and antimicrobial tolerance is not linked to kanamycin resistance selective 195 
marker used to detoxify φ24B. The kanamycin gene (aph3) used to detoxify the φ24B phage (18) is used as a 196 
selective marker only prior to experimentation. Through these studies there is no discernible metabolic burden or 197 
difference seen of encoding aph3 as there would be a consistency between the metabolic profiles when challenged 198 
with the 2 different antimicrobials. The discriminatory metabolites used in this analysis are discreet to the 2 199 
antibiotics tested. 200 
 201 
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Characterising the metabolites that discriminate between the naïve MC1061 and ɸ24B lysogen. The 202 
discriminatory metabolites determined from each test were compared with metabolite databases and were 203 
putatively identified based on exact mass and empirical formula (LCMS methods section). The identity of each 204 
metabolite was confirmed using fragmentation analysis using a secondary MS/MS stage. Identities with fragment 205 
similarity were found for 58 of the 81 metabolites discriminating between the naïve and lysogen. We focus here on 206 
6 particular metabolites as they have robust identities from fragmentation patterns, retention times, and low 207 
accurate mass error (PPM), relating to known curated bacterial metabolites (Table 4 SI). The 6 metabolites are: 208 
hexadecanoic acid (a fatty acid that is utilised in the construction of lipid A), sphinganine (putative kinase), 5-209 
Methyluridine (nucleotide synthesis, specifically pyrimidine), ophthalmic acid (glutathione analogue), pimelic acid 210 
and FAPy-Adenine, with PPM error margins of 0 ± 1 (0.17, -0.64, 0.45, 1.31, 0.56 and -1.00, respectively) and 211 
therefore most accurate identities in this study.  212 
The lysogen has significantly higher intensity levels of pimelic acid under all tests, specifically during early growth 213 
(Figure 5). FAPy-Adenine, a bacterial stress marker (45), is only seen in stressed conditions in these analyses, with 214 
the lysogen expressing significantly lower intensity during early growth and higher intensity at stationary phase 215 
growth (Figure 5). Hexadecanoic acid is identified in significantly higher abundance under cellular stress of 216 
chloroxylenol, and is further increased in the lysogen during early growth (P = 0.04). Metabolite sphinganine is 217 
present under standard conditions in higher intensity in the naïve MC1061. When challenged with chloroxylenol, 218 
intensity levels of sphinganine were undetectable in both naïve and lysogen during early growth. During mid-219 
exponential and stationary phase growth under choloroxylenol test there is > 100 fold increase in intensity of 220 
sphinganine in both the naïve and lysogen. 5-Methyluridine is present at stationary phase in all conditions, and is 221 
also identified in higher intensity when challenged with both antibiotics. Ophthalmic acid was present at all stages 222 
of growth under standard conditions where the lysogen shows lower intensity at early and mid-growth, and higher 223 
levels at stationary phase. When treated with either antimicrobial agent, ophthalmic acid was only present at 224 
stationary growth, with significantly higher intensity found in the lysogen (P = 0.001). During standard culture, 225 
there are 16 metabolites responsible for the differences seen between the core metabolic profiles of naïve host and 226 
lysogen during the 3 growth phases. Importantly 10 of these, including pimelic acid, are also present when the 227 
lysogen is challenged with chloroxylenol and 8-hydroxyquinoline.  228 
In the absence of antibiotics, the metabolite profile shows less discrimination between the lysogen and host at the 3 229 
stages of growth by PLS-DA (Figure 4A). Changes in individual metabolite abundances were measured as before 230 
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(Figure 4 and 6), and >100 were deemed possible biologically relevant metabolites. From the confirmed 231 
compounds, a total of 16 metabolites (SI table 3) were shown to discriminate between MC1061 and the φ24B 232 
lysogen.  233 
We further analysed these data using Hierarchical cluster analysis (HCA) and Euclidean dissimilarity matrix (DM) 234 
to create a heatmap that discriminates between 81 metabolites across all tests in this study (Figure 6). The heatmap 235 
was assembled unsupervised and unconstrained yet the metabolic profiles have separated by condition.  236 
Figure 6 illustrates differences between the metabolic profiles of the naïve MC1061 and φ24B lysogen when 237 
comparing both test antimicrobials and the standard culture conditions. Firstly there is the greatest dissimilarity 238 
when the naïve host or lysogen has been treated with a sub-inhibitory concentration of chloroxylenol. Within this 239 
grouping the naïve host shows the greatest difference in profile at stationary phase when treated. The chloroxylenol 240 
group is further stratified by whether the phage is present or absent. Presence of the phage offers the most 241 
dissimilar metabolic profile under this antimicrobial challenge. Treatment with 8-hydroxyquinoline has less impact 242 
on the metabolic profiles, yet the antimicrobial tolerance is still marked. The difference is also less marked as the 243 
profiles are stratified by growth phase rather than presence or absence of phage.  Importantly in Figure 6 244 
differences between the 81 metabolites in the naïve host and lysogen without challenging with an antimicrobial are 245 
still apparent. 246 
Discussion  247 
The accessory genome of bacteria promoted through horizontal gene transfer is important in understanding how 248 
transposable genetic elements aid selection in the environment. Metagenomics of DNA viruses in environmental 249 
and clinical samples has revealed a wide range of antimicrobial resistance genes (ARGs) (46-48). Enault et al., 250 
(2016) demonstrate that caution is needed as ARGs are over-estimated and therefore rarely found in phage 251 
genomes and that this over-estimation was further supported by functionality (49). We here propose a different 252 
mechanism promoted by Stx-phage φ24B, through infection and subversion of the cell physiology, promoting 253 
tolerance to sub-inhibitory concentrations of antimicrobials 8-hydroxyquinoline and chloroxylenol. Importantly, we 254 
show here that this tolerance is to antimicrobials commonly used in the farming industry globally. DeSmet et al., 255 
(2016) illustrated metabolomic differences during phage infection of P. aeruginosa (50), whereas this is the first 256 
reported use of a metabolic profiling approach to characterise the impact of temperate phage infection on the 257 
physiology of the bacteria under antimicrobial pressure. The impact of prophage should not be underestimated as 258 
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basis for metabolic variation and selection for the bacterial host by heightening or dampening cellular response to 259 
stress. With the altered metabolic profile of the φ24B lysogen and increased levels of biotin concentration and fatty 260 
acid intensities it leads to the hypothesis that altered growth and lipids may play a role in altering the cell surface 261 
that promotes antimicrobial exclusion. 262 
The metabolite pimelic acid is a precursor for the majority of the carbon atoms of biotin (51). Biotin plays a crucial 263 
role in cell metabolism via carboxylation and decarboxylation reactions. Beyond its function as a cofactor for 264 
carboxylases, biotin also plays a role in gene regulation in mammals (52). Unfortunately the mechanism of its 265 
action in E. coli is relatively unknown. However it has been shown that the E. coli BioC–BioH pathway uses a 266 
methylation and demethylation strategy to complete the necessary pimeloyl moiety (51). This methylation 267 
approach disguises the biotin synthetic intermediates such that they become substrates for the fatty acid synthetic 268 
pathway, and once the pimeloyl moiety is complete it is demethylated (51). We show here that the φ24B prophage 269 
has a significant upregulatory effect on biotin that links to other physiological pathways including fatty acid 270 
synthesis (51). Differences in pimelic acid intensities between lysogen and naïve host were greatest during early 271 
growth (Figure 5 1A, 2B, and 3A), which correlates with the differences observed in growth rates during the first 272 
2.5 hours of culture (Figure 1). This is associated with a ~3 fold increase in the level of biotin present per cell at 273 
mid-exponential growth phase (Figure 5 B3), which correlates to metabolite profiling for pimelic acid. This is the 274 
first time a phage has been shown to drive the biotin pathway.   275 
The Biolog data confirmed significant differences in rates of respiration between the naïve host and lysogen under 276 
different nutrient and chemical challenges. Interestingly the φ24B lysogens acquired the ability to respire using 277 
Uridine-2-Phosphate where the AURC is illustrated in Figure 2 A and SI Figure 1. U-2-P is involved in cellular 278 
metabolism (including biotin metabolism), nucleotide metabolism, pyrimidine metabolism and pyrimidine 279 
catabolism (53). Phages have been shown to subvert purine and pyrimidine synthesis to aid viral construction and 280 
proliferation (50, 54). Lysogen mediated differences encoded by φ24B also supports these numerous studies as 281 
metabolomics profiling identifies increased pyrimidine catabolism as 5-methyluridine intensity decreases in the 282 
lysogen sample. It has also been previously shown through metagenomic analysis that well adapted phages of 283 
Pseudomonas aeruginosa in the lung carry genes that are involved with purine, pyrimidine and different phosphate 284 
utilisation (55). This is further supported by Chevallereau, et al., (2016) who show marked changes in RNA 285 
metabolism during bacteriophage infection of P. aeruginosa (56).  Importantly, not only does φ24B lysogen show 286 
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increased pyrimidine utilisation it shows that phages can expand the group of phosphates E. coli can use for cell 287 
respiration and growth, in this instance U-2-P. 288 
Conversely to addition of function, integration of φ24B into the MC1061 chromosome confers an inability to 289 
respire using β-D- allose. The lysogen used in this study has φ24B inserted into the primary integration site on the 290 
E. coli genome ~ 250 bp downstream of intS (43). In E.coli there are 3 genes, alsB, alsA, and alsC, that are linked 291 
to the utilisation of D-allose (57), but are disparate (~700 Kbp) from any of the 6 integration sites reported by Fogg 292 
et al. (2007) (43). This is significant as it illustrates that integration can yield off target epigenetic effects. This 293 
study illustrates that the lysogen associated changes in fatty acid synthesis may exclude D-allose being transported 294 
into the bacterial cell. 295 
Previous research showed infection with λ increased cell growth by the lysogen under cell 296 
starvation/supplementation of glucose in a chemostat culture (58-60). This increase in growth rate is also seen with 297 
φ24B here. Interestingly we see a further increase with infection of a secondary, genetically identical phage. The 298 
double lysogen is an identical clone to that reported by Fogg et al., (2007), with phage integrating into the 299 
secondary integration site (43). When monitoring growth the single lysogen confers a doubling time of 17 mins 300 
compared to 20 mins for the naïve MC1061. This is also combined with shorter lag phases in both the single and 301 
double lysogen. It has been previously shown in many bacteria and yeast that augmenting a growing culture with 302 
biotin increases cell growth rates (61-65).  303 
When stressed with chloroxylenol, a demonstrated increase in lipid biosynthesis occurs in the lysogen presumably 304 
through subversion of the biotin pathway. This is supported through identification of higher intensity levels of 305 
hexadecanoic acid in the metabolite data. Hexadecanoic acid is involved in the biosynthesis of lipid A, a core outer 306 
cell membrane structure (66-68). Changes in hexadecanoic acid in the lipid A structure of E. coli have been 307 
previously shown to be associated to mutations in the firA gene (67, 69). The firA gene is essential for growth and 308 
outer membrane synthesis (70), and has also been shown as essential for rifampicin resistance associated with 309 
certain mutations in the β subunit of the RNA polymerase (68). This resistance and increase in hexadecanoic acid 310 
associated to the firA gene, shows that manipulation of this specific fatty acid likely improves antibiotic resistance. 311 
It is noteworthy that altering cell wall properties can broadly improve drug resistance (71), and the biotin pathway 312 
is intrinsically linked to cell wall synthesis and growth (51, 72). 313 
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The lysogen showed increased tolerance to 8-hydroxyquinoline and chloroxylenol using the Biolog phenotypic 314 
array and sub-inhibitory antimicrobial tests. An untargeted metabolomics approach demonstrated that phage 315 
conversion offers the bacterial host different metabolic profiles to tolerate the two antimicrobials tested. The 316 
tolerance observed also suggests core functional changes allow the cell to resist two disparate antimicrobials. This 317 
may suggest that these lysogen associated metabolic differences would likely infer tolerance to other environmental 318 
challenges and selective pressures.  319 
Firstly, we present a metabolic difference in growth under standard culture conditions between the naïve MC1061 320 
and the φ24B lysogen. From 81 metabolites, 16 were discriminatory between the Lysogen and MC1061 (SI table 3). 321 
Pimelic acid is present and constitutively raised after infection by φ24B. We also showed here a difference between 322 
metabolites at the 3 key stages of growth. These again differ between the lysogen and MC1061 (Figure 6).  323 
Under treatment with chloroxylenol in early growth, increased intensity of hexadecanoic acid was identified, 324 
particularly in the lysogen. The metabolite sphinganine was observed in our data, sphinganine plays an essential 325 
part in the sphingolipid synthesis pathway (73). In both the lysogen and naïve host there is evidence of higher 326 
intensities of a sphinganine under chloroxylenol treatment and at stationary growth in standard conditions (Figure 327 
6). In Shigella species, a pathway associated with mammalian sphingolipid based rafts has been linked to improved 328 
binding and mammalian host cell entry (74). 329 
Metabolic differences between the lysogen and naïve bacteria are the most disparate when under challenge of a 330 
sub-inhibitory concentration of chloroxylenol, illustrated in the PLS-DA plots (Figure 4) and heatmap (Figure 6). 331 
Chloroxylenol is a bactericidal agent and a halophenol that targets microbial membranes (71) with a broad activity 332 
as an antimicrobial (75).  333 
Tolerance to antimicrobial 8-hydroxyquinoline is also reported here. Interestingly, compared to stress under 334 
chloroxylenol, the 8-hydroxyquinoline tested metabolite profile changes less significantly from standard 335 
conditions.  Furthermore when treated with 8-hydroxyquinoline, the metabolite profile is less pronounced in the 336 
lysogen when compared to the chloroxylenol test. 8-hydroxyquinoline is a lipophilic metal-chelator with 337 
intracellular targets (76). It inhibits growth by chelating metal ions, e.g. Zn2+ on RNA polymerase (77, 78). The 338 
changes in the intensity of lipids present at the cell surface, that we previously suggest effect uptake of D-allose, 339 
are similarly likely to inhibit levels of these 2 antimicrobials entering the cell. 340 
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When testing cellular stress it is imperative to find markers of inhibition detailed in the metabolite data. The 341 
metabolomic profiles identified 2 discriminatory metabolites that are associated with cellular stress: FAPy-Adenine 342 
(45) and ophthalmic acid (79, 80). Our data showed that FAPy-Adenine was only present when cells were 343 
challenged by the antimicrobials 8-hydroxyquinoline and chloroxylenol. Interestingly the intensity levels of FAPy-344 
adenine differ greatly depending on the antimicrobial used and also presence or absence of integrated φ24B (Figure 345 
5). In the presence of chloroxylenol the lysogen demonstrates lower intensities of the stress marker (0.56 fold less 346 
in early growth phase and 0.37 fold reductions in mid-exponential growth phase, (Figure 5 2a & b)) but higher 347 
intensity of pimelic acid compared to MC1061. This strengthens the hypothesis of a biotin related lipid increase or 348 
change at the cell surface lowering levels of the drug reaching its intracellular target.  349 
When challenging the culture with 8-hydroxyquinoline, FAPy-adenine intensity increases rapidly, even more so 350 
than the naïve host (Figure 5). Again there is an increase in pimelic acid intensity that is ubiquitous to the metabolic 351 
profiles in the presence of an integrated φ24B, however hexadecanoic acid was undetectable within the cell, which 352 
may be associated with the lipophilic nature of the drug. The stress response occurs directly after treating with 8-353 
hydroxyquinoline and likely promotes some cell death. Extracellular lipids released through cell lysis binds the 354 
drug, forming a matrix. This therefore would reduce the concentration of the available drug present allowing the 355 
bacterial culture to grow.  356 
The second stress marker ophthalmic acid is an analogue of glutathione and a reported marker of oxidative stress 357 
(79, 80). Opthalmic acid intensity mirrored the stationary phase levels of FAPy-adenine, across all tests, however it 358 
was also present in standard culture conditions in both the early and mid-exponential growth phase cultures. This 359 
observation from our metabolomic analysis implies higher oxidative stress in the lysogen at stationary growth, as 360 
the data are supported by Desnues et al. (2003) (80). The oxidative stress also correlates with the reduction in 361 
growth rate and a reduction in the intensity of pimelic acid.  362 
This study has established that Stx-phage φ24B provides a ‘jump start’ in early respiration and increased bacterial 363 
growth rates. These phage-mediated alterations in bacterial host metabolic profile may offer positive selection for 364 
the lysogen. Subversion of the biotin pathway is core to the changes mediated by φ24B as it links to the bacterium 365 
becoming able to tolerate chloroxylenol and 8-hydroxyquinoline during early and mid-exponential growth phase. 366 
These tolerances are important as both antimicrobials are used globally in livestock farming. Importantly metabolic 367 
shift and subversion offers 2 mechanisms of controlling this antimicrobial tolerance through increased biotin and 368 
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fatty acid synthesis. With treatment and tolerance to choloroxylenol, alteration in levels of lipid A and presumably 369 
other lipids enables exclusion of the drug from entry. Secondly 8-hydroxyquinoline treatment drives early cellular 370 
stress, cell death and lysis which increases extracellular lipids that bind free drug, allowing the community to 371 
continue to grow.  372 
The mechanism for this is unclear, yet this is importantly linked to subversion of the bacterial cell because no 373 
phage encoded metabolites are present. We therefore propose that temperate phages may not carry ARGs but play a 374 
larger role interfering with metabolic regulation that alters bacterial sensitivity to antimicrobials. 375 
 376 
Materials and Methods 377 
Bacterial strains and growth conditions - Buffer and Agar 378 
All bacterial strains were grown in Lysogeny Broth + 0.01 M CaCl2 (LB). Growth of the MC1061(φ24B:: Kan), a 379 
lysogen of the bacteriophage φ24B::Kan and growth of the MC1061(φ24B:: Cat), a lysogen of the bacteriophage 380 
φ24B::Cat (54) was supplemented with 50 µg.ml-1 kanamycin (kan) and Chloramphenicol (cat) respectively (55). 381 
Bottom agar plates for plaque assay included LB broth (56)) including 7 % (w/v) grade 1 agar (57). Soft top agar 382 
was contained LB broth plus 0.4 % (w/v) grade 1 agar. Unless otherwise stated culture conditions were at 37 °C, 383 
and broth cultures were shaken at 200 rpm. 384 
Growth curve of single and double lysogens 385 
A single colony of either naïve MC1061, single or double lysogen was cultured overnight for 18 h (200 rpm). LB 386 
with 0.01M CaCl2 (100 ml) was inoculated with 1 % (v/v) of the overnight culture. Samples were taken over a 7 387 
hour period, subject to serial, ten-fold dilutions and spread plated on LB agar plates.  388 
 389 
Bacterial phenotypic microarray - Biolog 390 
The Biolog assay utilises a redox dye where a tetrazolium violet salt acts as an electron receptor from the 391 
tricarboxylic cycle and reduction to NADH. The transfer alters the clear salt to a purple formazan dye that is 392 
inexplicably linked to the cellular activity, specifically cell respiration. An inoculum was taken from an 18 h 393 
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streaked plate of either MC1061 or φ24B lysogen, raised through 2 rounds of passage from single colony 394 
amplification from cryo-stock. A single colony was added to fluid IF-0 (containing 50 µM leucine due to MC1061’s 395 
auxotrophy), to a transmittance of 42% T on a Biolog turbidometer in a 20 mm diameter tube as per 396 
manufacturer’s instructions and used to inoculate Biolog Phenotypic Microarray plates. 397 
 398 
The panel plates used for this study included Biolog plates PM 1-20, which include a range of both metabolic and 399 
toxicological additives (see SI). Further details of the components associated with these PM plates can be found at 400 
http://www.biolog.com/pmMicrobialCells.html. The Biolog PM plates were grown at 37 °C and monitored using 401 
the Omnilog plate reader at 30 min intervals over 47 hours.  402 
 403 
Sub-inhibitory concentration (SIC) assay 404 
Again as per Biolog assay an inoculum of for the MC1061 or lysogen, for a transmittance of 42 % T was created in 405 
the same manner. An identical volume of inoculum was added to an equal volume of antimicrobial (double 406 
concentrate) diluted in LB broth. Readings were taken at 0 and 18 hours; plates were incubated at 37 °C.  407 
 408 
SIC assay – Liquid chromatography mass spectrometry (LCMS) analysis comparing metabolic compounds 409 
from Naïve host and Lysogens. 410 
Replicated in triplicate therefore n=9 bacterial cultures (10 ml) were grown as previously described under 411 
standard growth conditions and challenged with antimicrobials, the cells were harvested at early, mid, and late 412 
log phase. The cells were harvested by centrifugation (5,000 rpm for 5 min) and the pellet washed (x3) in ice cold 413 
1 x PBS prior to lyophilisation. Lyophilised samples (x3) were pooled, normalised for weight/vol (normalised to 1 414 
mg.ml) with methanol and 0.1% formic acid, this was vortexed and then sonicated (Bandelin Sonorex, Sonicator) 415 
for 1 hour and centrifuged (5k rpm for 5 mins). The supernatant was recovered and filtered through 0.22 µm 416 
pore-sized, nylon filter and injected into the Q-Exactive LC-MS (Thermo-Fisher) after separation on a Phenomenex 417 
Gemini column (110A, 150x2mm, 5µm, flow 0.2 ml.min). LCMS mobile phase parameters were: 0-6 mins at 20% 418 
ACN, 8 mins 60% ACN, 12 mins 95% ACN, 17 mins 95% ACN, 17.1 -23 mins 5% CAN. MS conditions were: full MS 419 
mode, resolution 70, 000, AGC target 1x106, maximum IT 200ms, scan range 150-2000, column temperature 35 420 
°C. Progenesis QI software was used for raw data analysis; this software provided alignment, peak picking, 421 
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pairwise statistical analysis and putative metabolite ID based on accurate mass. Metabolites were confirmed by 422 
analysing pure standards and MSMS fragmentation analysis run under identical analytical conditions. 423 
Biotin quantification assay 424 
Inoculums were prepared in the same manner as for the SIC and Biolog assays. Optical density values were taken 425 
at 0 and 18 h, incubation at 37 °C. The cultures were diluted to the lowest OD600 reading to normalise cell number 426 
between naïve MC1061 and lysogen. Dilutions of both naïve MC1061 and lysogen were made in LB (1:100 and 427 
1:1000). Cells were harvested by centrifugation (5,000 rpm for 5 mins). The biotin assay was completed using the 428 
Bio Vision® (Cambridge, UK) Biotin Quantitation Kit (Colorimetric) according to the manufacturer’s protocol. In 429 
brief, the supernatant was discarded and the pellet re-suspended in 10 µl PBS and heated to 100 °C for 3 min and 430 
then immediately placed on ice. Diluted naïve and lysogen cells (10 µl) were added to individual aliquots of Biotin 431 
Assay buffer (20 µl ) and 300 µl of biotin reaction mix, pre-prepared as described in the Biotin Quantitation Kit 432 
protocol (version 7.6), was added to the buffer and cells. The mix was incubated at 21 °C for 15 min. Each sample 433 
mix (150 µl) was then pipetted into a microtitre plate and read at 500 nm. A standard curve was prepared as per 434 
manufacturer’s instructions.  435 
Statistical analysis 436 
To determine statistically significant difference between growth rates of the single and double φ24B lysogen 437 
compared to MC1061, paired-sample T-tests in the statistical package SPSS was used. The two tailed p values are 438 
given at 95% confidence limits. The statistically significant difference in SIC between lysogen and MC1061 was 439 
calculated using an independent t-test, using the SPSS platform (> 95 % confidence limits). The Biolog area under 440 
the respiration curve (AURC) for respiration values were calculated using a trapezoid algorithm (58). Statistical 441 
significance of area under the respiration curve (AURC) and comparison at a specific time point during mid 442 
exponential growth phase was achieved by determining  normal Gaussian distribution by parametric analysis and 443 
statistical significance identified using an un-paired t test (> 95% confidence limits). Metabolomic analysis was 444 
carried out primarily by Progenesis QI software, this software provided alignment, peak picking, pairwise 445 
statistical analysis and putative metabolite ID based on accurate mass. Further multivariate analysis was 446 
performed using SIMCA-P. ID’s were obtained through the QI plugin ’Progenesis metascope’ and filtered through 447 
a range of databases using sdf files (ECMDB, HMDB, small molecules drugs, Biomolecules, analgesics mix, Lipid 448 
18 
MBD, Basic lipids, and Yeast DB). A paired sample t test was used to determine statistically significant differences 449 
between intensities of metabolites identified during metabolomic analyses (> 95% confidence limits). 450 
 451 
 452 
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Figure Legends 665 
 666 
 667 
Figure 1| Clustered column graph representing percentage increase in cell proliferation of single (φ24B::ΔKan, 668 
dark grey) and double (φ24B::ΔKan, φ24B::ΔCat, light grey) MC1061 lysogens. Cultures were grown at 37 °C 669 
24 
(CFU.ml) and samples taken over a 7 hour period including experimental and technical replicates (n=9). 670 
Percentage increases or decreases show differences in growth of the lysogens compared to the uninfected 671 
MC1061 represented here as 0 on the x axis. Significance threshold P values *** <0.001, ** <0.01, * <0.05, 672 
significance below the x axis demonstrates greater growth from the Naïve host. 673 
 674 
Figure 2 | A comparison of Area Under the Respiration Curve (AURC) data from the Biolog bacterial phenotypic 675 
microarray. Data plotted shows the addition of supplemented nutrients or chemical challenge showed 676 
statistically significant difference in rates of respiration between the lysogen and naïve MC1061 host (for P values 677 
see SI Table 2). Arbitrary Omnilog fluorescence values (y-axis) show differences between the naïve MC1061 (light 678 
grey) host and the lysogen (dark grey) over a 47.5 h time period (n=3). Error bars represent SEM. Graphs A-F show 679 
significantly higher amount of respiration of the lysogen compared to the naïve host under the following 680 
conditions; (A) U-2-monophosphate, (B) 8-hydroxyquinoline, (C) chloroxylenol, (D) cefoxitin, (E) cefomendole and 681 
(F) amoxacillin. Graphs G-I show mean AURC values where growth on different carbon sources or chemical 682 
challenge that has a detrimental effect on the respiration of MC1061 when converted by φ24B, these inculde; (G) 683 
-D-Allose, (H) ofloxacin and (I) oxolinic acid. 684 
 685 
Figure 3| Dose response in growth of both MC1061 (light grey) and the ɸ24B lysogen (Dark grey) to an 686 
increasing concentration of (A) 8-hydroxyquinoline, (B) chloroxylenol, and (C) oxolinic acid. Bacterial growth 687 
was measured by increase in optical density at 600nm after 18 hours growth at 37°C, as per original Biolog assay. 688 
Error bars represent the standard error of the mean (SEM) (n=12). Significance represented by (P) thresholds; *** 689 
<0.001, ** <0.01, * <0.05.  690 
 691 
Figure 4| A, B and C: The metabolite profiles of MC1061 versus lysogen and multivariate analysis using partial 692 
least discriminant analysis (PLS-DA). The panels represent score plots from PLS-DA models of: (A) Standard 693 
growth conditions, and supplementation with (B) 8-hydroxyquinoline and (C) chloroxylenol, between the naïve 694 
host (light grey spot) and lysogen (dark grey spot), the model discriminatory parameters for the PLS-DA analysis 695 
are described in the results section and in SI table 5. 696 
25 
 697 
Figure 5| Biotin concentration, FAPy-Adenine and pimelic acid intensity showing significant biological 698 
differences between naïve host and lysogen during growth and antimicrobial challenge. A1: Changes in cellular 699 
stress marker FAPy-Adenine abundances under the challenge of chloroxylenol at early, mid and stationary growth 700 
between the lysogen (dark grey) and naive Host (light grey). B1: Average pimelic acid abundance under 701 
chloroxylenol at early, mid and stationary growth between the lysogen and naive Host. A2: Average FAPy-Adenine 702 
abundances under selective pressure of 8-hydroxyquinoline at early, mid and stationary growth between the 703 
lysogen and naive MC1061. B2: Average pimelic acid abundances under challenge with 8-hydroxyquinoline at 704 
early, mid and stationary growth between the lysogen and naive Host. A3: Average pimelic acid abundances 705 
under standard conditions at early, mid and stationary growth between the lysogen and naive Host. B3: Variance 706 
in the amounts of Biotin present in samples of Ф24B lysogen and MC1061 naïve Host. Error bars derived from 707 
standard error of the mean (n=3). Biotin Quantitation test performed using BioVision® quantitation kit (7.5) using 708 
a modified protocol. Two tailed significance represented by *** <0.001, ** <0.01, * <0.05, key: *Inc. = Increase, 709 
*expo = exponential growth. 710 
Figure 6| Heatmap generated by metabolic levels of 81 metabolites using HCA and DM Culture conditions and 711 
presence or absence of phage can be found alongside each profile (H = 8-hydroxyquinoline, C = chloroxylenol). 712 
Each individual tile represents a metabolite. The colour of a given tile denotes higher or lower intensity of the 713 
metabolite. The colour scale key is: dark blue: lowest levels; white: mid-point; dark red: highest level. The gradient 714 
between these colours represents variation in the levels of the metabolite across the colour scale (putative ID’s can 715 
be found in SI table 3). Pimelic acid is highlighted across all profiles with a hatched box. 716 
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